Sign Up Today and Learn More About DiscGenics Stock
Invest in or calculate the value of your shares in DiscGenics or other pre-IPO companies through EquityZen's platform.
DiscGenics Stock
Regenerative Cell Therapy for Chronic Back Pain.
About DiscGenics Stock
Founded
2007
Headquarters
Salt Lake City, UT, US
Industries
Software, Artificial Intelligence, Data and Analytics
DiscGenics Press Mentions
Stay in the know about the latest news on DiscGenics
DiscGenics’ Regenerative Spine Therapy Named Top Spine Surgery Study of 2024
techbuzznews • Apr 12, 2025
Peer-Reviewed Article Reporting DiscGenics' Cell Therapy Phase I/II Study Results Receives International Journal of Spine Surgery Best Paper Award
prnewswire • Apr 09, 2025
Peer-Reviewed Article Reporting DiscGenics' Cell Therapy Phase I/II Study Results Receives International Journal of Spine Surgery Best Paper Award
morningstar • Apr 09, 2025
Novel methods for production of therapeutic mammalian cells and cell spheres …
patents • Apr 02, 2025
Isolated discogenic cells, methods of using, and methods of preparing same from …
patents • Feb 09, 2025
DiscGenics Management
Leadership team at DiscGenics
Board Chairman
Flagg Flanagan
Investor
Rand Page
Join now and verify your accreditation status to gain access to:
- DiscGenics Current Valuation
- DiscGenics Stock Price
- DiscGenics Management
- Available deals in DiscGenics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- DiscGenics Cap Table and Funding History by Share Class and Liquidity Preferences
- DiscGenics Revenue and Financials
- DiscGenics Highlights
- DiscGenics Business Model
- DiscGenics Risk Factors
- DiscGenics Research Report from SACRA Research
Trading DiscGenics Stock
How to invest in DiscGenics stock?
Accredited investors can buy pre-IPO stock in companies like DiscGenics through EquityZen funds. These investments are made available by existing DiscGenics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell DiscGenics stock?
Shareholders can sell their DiscGenics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."